|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-2-1
|
|
pubmed:abstractText |
Infiltrating MBC represents less than 1% of all male cancers. Our study details clinico-pathological features, treatments and prognostic factors in a large French cohort.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1879-0461
|
|
pubmed:author |
pubmed-author:BelkacemiYY,
pubmed-author:CometBB,
pubmed-author:CutuliBB,
pubmed-author:De LafontanBB,
pubmed-author:DelvaCC,
pubmed-author:EdelineJJ,
pubmed-author:GadaMM,
pubmed-author:KirovaYY,
pubmed-author:Le-NirC Cohen-SolalCC,
pubmed-author:LemanskiCC,
pubmed-author:MaingonPP,
pubmed-author:MignotteHH,
pubmed-author:Penault-LlorcaFF,
pubmed-author:RomestaingPP,
pubmed-author:SerioGG,
pubmed-author:ZoubirMM,
pubmed-author:de LaraC TunonCT
|
|
pubmed:copyrightInfo |
Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
73
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
246-54
|
|
pubmed:meshHeading |
pubmed-meshheading:19442535-Adult,
pubmed-meshheading:19442535-Aged,
pubmed-meshheading:19442535-Aged, 80 and over,
pubmed-meshheading:19442535-Antineoplastic Agents, Hormonal,
pubmed-meshheading:19442535-Aromatase Inhibitors,
pubmed-meshheading:19442535-Breast Neoplasms, Male,
pubmed-meshheading:19442535-Cohort Studies,
pubmed-meshheading:19442535-Humans,
pubmed-meshheading:19442535-Male,
pubmed-meshheading:19442535-Mastectomy,
pubmed-meshheading:19442535-Middle Aged,
pubmed-meshheading:19442535-Prognosis,
pubmed-meshheading:19442535-Tamoxifen,
pubmed-meshheading:19442535-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases.
|
|
pubmed:affiliation |
Radiation Oncology Department, Polyclinique de Courlancy, 38 rue de Courlancy, 51100 Reims, France. bcutuli@oncorad.courlancy.fr
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
